Pharmassist participates in 3rd ACTC "Liquid Biopsy in Clinical Practice" meeting in Rhodes

The 3rd ACTC meeting is focused on “Liquid Biopsy in clinical practice” by bringing together researchers and clinicians to discuss practical implementation of CTCs and ctDNA and translate much of the excellent basic research in this field into clinical practice. The most prominent and established researchers in the field will present state of the art research on the technical advancements in the isolation, and detection of CTCs, ctDNA, miRNAs and exosomes as well as on the potential of Liquid Biopsy analysis in clinical practice. Latest findings on the clinical applications of liquid biopsy in prognosis and real time monitoring of systemic anticancer therapies will be discussed. 

The ACTC meeting will be as interactive as possible and stimulate intense discussions between basic and clinical researchers, as well as Diagnostics and Pharma-industry companies that are active in this exciting field. Networking and knowledge sharing across basic researchers, clinicians and Diagnostics and Pharma-industry companies will be an important part of this event.

Wednesday, 4 October, 2017 to Saturday, 7 October, 2017
Rhodes, Greece
VenueRodos Palace International Convention Center